Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
26 readers recommended
Eli Lilly to donate 200,000 insulin pens and provide $2 million for diabetes education to 200 free clinics across the United States by 2022
82 readers recommended
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
48 readers recommended
Farxiga becomes the first SGLT-2 inhibitor drug approved to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and heart disease or...
39 readers recommended
Did your insurance or pharmacy switch your medication, without your medical professional knowing? This is called non-medical switching. Learn what you can do about it
43 readers recommended
A currently-recruiting trial is comparing how two types of basal insulin – Toujeo and Tresiba – impact blood sugar levels in adults, using continuous glucose monitoring
53 readers recommended
$99 Cash Card Program provides 3000-3800 units of any combination of Novo Nordisk analog insulins in vials or pens. NovoLog authorized generics are available at half...
25 readers recommended
The Medicine Assistance Tool (MAT) is a search engine to help find patient assistance resources for your medications
35 readers recommended
For now, another SGLT-2 inhibitor pill already approved for people with type 2 diabetes is not approved for people with type 1 diabetes in the US. The drug was recently...
28 readers recommended
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels
98 readers recommended
Ozempic, a once weekly injectable GLP-1 agonist drug, is now approved to reduce the risk of heart attack and stroke. Rybelsus (a pill version of Ozempic) is confirmed to...
38 readers recommended
The SGLT-2 inhibitor becomes the first diabetes medicine approved to treat kidney disease and reduce the risk of hospitalization for heart failure in people with type 2...
29 readers recommended
The FDA finds that some versions of extended-release metformin contain excessive amounts of a cancer-causing chemical called NDMA
27 readers recommended
Under the rule, people using prescription discount coupons would have to spend more money in order to meet their deductibles
35 readers recommended
¿Te diagnosticaron hace poco diabetes tipo 2? La Dra. Francine Kaufman responde algunas de las preguntas más frecuentes para adolescentes con diabetes tipo 2
29 readers recommended
States have been working furiously during the COVID-19 pandemic to limit monthly out-of-pocket expenses on insulin
54 readers recommended
Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications
48 readers recommended
Two exciting technology partnerships were recently announced: Medtronic will acquire Companion Medical in the next few months to advance insulin delivery and increase...
54 readers recommended
Nurse and diabetes educator (and person with type 2 diabetes in remission!) Michael Hattori introduces seven self-care behaviors that provide a foundation for managing...
40 readers recommended
The Association of Diabetes Care and Education Specialists 2020 conference covered the benefits of sleep education for diabetes management, medications that support...